BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

332 related articles for article (PubMed ID: 38363565)

  • 1. Health Economic Consequences Associated With COVID-19-Related Delay in Melanoma Diagnosis in Europe.
    Maul LV; Jamiolkowski D; Lapides RA; Mueller AM; Hauschild A; Garbe C; Lorigan P; Gershenwald JE; Ascierto PA; Long GV; Wang-Evers M; Scolyer RA; Saravi B; Augustin M; Navarini AA; Legge S; Németh IB; Jánosi ÁJ; Mocellin S; Feller A; Manstein D; Zink A; Maul JT; Buja A; Adhikari K; Roider E
    JAMA Netw Open; 2024 Feb; 7(2):e2356479. PubMed ID: 38363565
    [TBL] [Abstract][Full Text] [Related]  

  • 2. The impact of the COVID-19 pandemic on the diagnosis of cutaneous melanomas: A retrospective cohort study from five European skin cancer reference centres.
    Troesch A; Hoellwerth M; Forchhammer S; Del Regno L; Lodde G; Turko P; Cheng PF; Levesque ML; Hadaschik E; Livingstone E; Peris K; Flatz L; Koelblinger P; Dummer R; Dimitriou F
    J Eur Acad Dermatol Venereol; 2023 May; 37(5):922-931. PubMed ID: 36785973
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Association of Simulated COVID-19 Policy Responses for Social Restrictions and Lockdowns With Health-Adjusted Life-Years and Costs in Victoria, Australia.
    Blakely T; Thompson J; Bablani L; Andersen P; Ait Ouakrim D; Carvalho N; Abraham P; Boujaoude MA; Katar A; Akpan E; Wilson N; Stevenson M
    JAMA Health Forum; 2021 Jul; 2(7):e211749. PubMed ID: 35977202
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Disability adjusted life years associated with COVID-19 in Denmark in the first year of the pandemic.
    Pires SM; Redondo HG; Espenhain L; Jakobsen LS; Legarth R; Meaidi M; Koch A; Tribler S; Martin-Bertelsen T; Ethelberg S
    BMC Public Health; 2022 Jul; 22(1):1315. PubMed ID: 35804310
    [TBL] [Abstract][Full Text] [Related]  

  • 5. [Evaluation of the burden of diabetes in Poland].
    Kissimova-Skarbek K; Pach D; Płaczkiewicz E; Szurkowska M; Szybiński Z
    Pol Arch Med Wewn; 2001 Sep; 106(3):867-73. PubMed ID: 11928598
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Cost of disorders of the brain in Europe 2010.
    Gustavsson A; Svensson M; Jacobi F; Allgulander C; Alonso J; Beghi E; Dodel R; Ekman M; Faravelli C; Fratiglioni L; Gannon B; Jones DH; Jennum P; Jordanova A; Jönsson L; Karampampa K; Knapp M; Kobelt G; Kurth T; Lieb R; Linde M; Ljungcrantz C; Maercker A; Melin B; Moscarelli M; Musayev A; Norwood F; Preisig M; Pugliatti M; Rehm J; Salvador-Carulla L; Schlehofer B; Simon R; Steinhausen HC; Stovner LJ; Vallat JM; Van den Bergh P; van Os J; Vos P; Xu W; Wittchen HU; Jönsson B; Olesen J;
    Eur Neuropsychopharmacol; 2011 Oct; 21(10):718-79. PubMed ID: 21924589
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Diagnostic Delays for Non-melanoma Skin Cancers in Renal Transplant Recipients during the COVID-19 Pandemic: What is Hiding Behind the Mask?
    Mokos M; Bašić-Jukić N
    Acta Dermatovenerol Croat; 2021 Jul; 29(2):111-113. PubMed ID: 34477079
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Impact of the Burden of COVID-19 in Italy: Results of Disability-Adjusted Life Years (DALYs) and Productivity Loss.
    Nurchis MC; Pascucci D; Sapienza M; Villani L; D'Ambrosio F; Castrini F; Specchia ML; Laurenti P; Damiani G
    Int J Environ Res Public Health; 2020 Jun; 17(12):. PubMed ID: 32545827
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Limited impact of COVID-19-related diagnostic delay on cutaneous melanoma and squamous cell carcinoma tumour characteristics: a nationwide pathology registry analysis.
    Sangers TE; Wakkee M; Kramer-Noels EC; Nijsten T; Louwman MWJ; Jaspars EH; Hollestein LM
    Br J Dermatol; 2022 Aug; 187(2):196-202. PubMed ID: 35141890
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Disability-adjusted life years (DALYs) due to the direct health impact of COVID-19 in India, 2020.
    Singh BB; Devleesschauwer B; Khatkar MS; Lowerison M; Singh B; Dhand NK; Barkema HW
    Sci Rep; 2022 Feb; 12(1):2454. PubMed ID: 35165362
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Effectiveness and cost-effectiveness of four different strategies for SARS-CoV-2 surveillance in the general population (CoV-Surv Study): a structured summary of a study protocol for a cluster-randomised, two-factorial controlled trial.
    Deckert A; Anders S; de Allegri M; Nguyen HT; Souares A; McMahon S; Boerner K; Meurer M; Herbst K; Sand M; Koeppel L; Siems T; Brugnara L; Brenner S; Burk R; Lou D; Kirrmaier D; Duan Y; Ovchinnikova S; Marx M; Kräusslich HG; Knop M; Bärnighausen T; Denkinger C
    Trials; 2021 Jan; 22(1):39. PubMed ID: 33419461
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Direct impact of COVID-19 by estimating disability-adjusted life years at national level in France in 2020.
    Haneef R; Fayad M; Fouillet A; Sommen C; Bonaldi C; Wyper GMA; Pires SM; Devleesschauwer B; Rachas A; Constantinou P; Levy-Bruhl D; Beltzer N; Gallay A
    PLoS One; 2023; 18(1):e0280990. PubMed ID: 36693071
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Cost of depression in Europe.
    Sobocki P; Jönsson B; Angst J; Rehnberg C
    J Ment Health Policy Econ; 2006 Jun; 9(2):87-98. PubMed ID: 17007486
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Did COVID-19 lockdown delay actually worsen melanoma prognosis?
    Gil-Pallares P; Figueroa-Silva O; Gil-Pallares ME; Vázquez-Bueno JÁ; Piñeyro-Molina F; Monteagudo B; Heras-Sotos CL
    An Bras Dermatol; 2023; 98(2):176-180. PubMed ID: 36567164
    [TBL] [Abstract][Full Text] [Related]  

  • 15. The burden of disease due to COVID-19 in Sweden 2020-2021: A disability-adjusted life years (DALYs) study.
    Shedrawy J; Ernst P; Lönnroth K; Nyberg F
    Scand J Public Health; 2023 Jul; 51(5):673-681. PubMed ID: 36941820
    [TBL] [Abstract][Full Text] [Related]  

  • 16. A Reminder of Skin Cancer During the COVID-19 Pandemic.
    Šitum M; Filipović N; Buljan M
    Acta Dermatovenerol Croat; 2021 Apr; 291(1):58. PubMed ID: 34477068
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Melanoma burden by melanoma stage: Assessment through a disease transition model.
    Tromme I; Legrand C; Devleesschauwer B; Leiter U; Suciu S; Eggermont A; Francart J; Calay F; Haagsma JA; Baurain JF; Thomas L; Beutels P; Speybroeck N
    Eur J Cancer; 2016 Jan; 53():33-41. PubMed ID: 26693897
    [TBL] [Abstract][Full Text] [Related]  

  • 18. The Economic Impact of Smoking and of Reducing Smoking Prevalence: Review of Evidence.
    Ekpu VU; Brown AK
    Tob Use Insights; 2015; 8():1-35. PubMed ID: 26242225
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Estimating global burden of COVID-19 with disability-adjusted life years and value of statistical life metrics.
    Fan CY; Fann JC; Yang MC; Lin TY; Chen HH; Liu JT; Yang KC
    J Formos Med Assoc; 2021 Jun; 120 Suppl 1():S106-S117. PubMed ID: 34119392
    [TBL] [Abstract][Full Text] [Related]  

  • 20. The Effect of the COVID-19 Lockdown on Melanoma Diagnosis in Italy.
    Gualdi G; Porreca A; Amoruso GF; Atzori L; Calzavara-Pinton P; De Tursi M; Buduo AD; Marino PD; Fabroncini G; Fantini F; Fargnoli MC; Giannotta G; Lacarruba F; Lotesoriere A; Merli M; Micali G; Paradisi A; Puviani M; Quaglino P; Rongioletti F; Rubatto M; Sbano P; Scalvenzi M; Soglia S; Sollima L; Villani A; Nicola MD; Amerio P
    Clin Dermatol; 2021; 39(5):911-919. PubMed ID: 34785022
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 17.